Similar to HMGA1 deficiency, silencing GATA2 in JAK2V617F AML cell lines decreased leukemogenic properties in vitro and in vivo, recapitulating most, but not all of the phenotypes observed with HMGA1 deficiency [48]. This evidence concerns the gene GATA2 and acute myeloid leukemia.